Immune System News and Research

RSS

Houston scientists receive $1.3M grant to study how immune system drives multiple sclerosis

A $1.3 million grant from the National Institute of Neurological Disorders and Stroke could help Houston Methodist scientists better understand how the body's own immune system drives multiple sclerosis.

26 Aug 2013

Model including dozens of mutations helps clarify genetic factors involved in Crohn's disease

A statistical model accounting for dozens of different genes in combination-and the interactions between them-is an important step forward in understanding the genetic factors affecting the risk of Crohn's disease (CD), reports a study in Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America (CCFA). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

26 Aug 2013

BES procedure may prevent cell apoptosis in stem cell-based transplantation therapy

Researchers at the Beihang University School of Biological Science and Medical Engineering, led by Dr. Yubo Fan, have discovered that Biphasic Electrical stimulation (BES), a non-chemical procedure, may be used as a strategy for preventing cell apoptosis in stem cell-based transplantation therapy.

26 Aug 2013

Early antiretroviral therapy treatment benefits HIV-infected infants

Giving antiretroviral therapy immediately after diagnosis for a limited period of time is more beneficial than postponing treatment in young infants infected with HIV, slowing progression of the disease and delaying the time to starting long-term ART, according to new research published in The Lancet.

23 Aug 2013

Hope for hand amputees: Researchers test new method for local immunosuppression

Hope for hand amputees: researchers at Inselspital and the University of Bern have successfully tested a new method for local immunosuppression.

23 Aug 2013

Understanding genetic factors that affect Crohn's disease risk

A statistical model accounting for dozens of different genes in combination—and the interactions between them—is an important step forward in understanding the genetic factors affecting the risk of Crohn's disease, reports a study in Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America.

23 Aug 2013

Moffitt Cancer Center study could offer hope to melanoma sufferers

A new study at Moffitt Cancer Center could offer hope to people with melanoma, the deadliest form of skin cancer. Researchers are investigating whether an injectable known as PV-10 can shrink tumors and reduce the spread of cancer.

23 Aug 2013

Seven researchers to receive grants from ASTRO to advance radiation oncology research

The American Society for Radiation Oncology (ASTRO) has selected seven (7) leading researchers who will receive a total of $675,000 in awards and grants to advance radiation oncology research.

23 Aug 2013

ATF3 gene may be the crucial link between stress and breast cancer: Study

In an unexpected finding, scientists have linked the activation of a stress gene in immune-system cells to the spread of breast cancer to other parts of the body.

23 Aug 2013

Study shows how microbes cooperate with sex hormones to affect immune system

Females can mount more powerful immune responses than males, but the flip side of this enhanced protection against infections is a greater risk for autoimmune disorders. Shedding light on the underlying causes of the gender bias in autoimmune diseases, a study published by Cell Press August 22nd in the journal Immunity reveals that certain gut microbes prevalent in males can help protect them against type 1 diabetes.

23 Aug 2013

Noninvasive urine test can accurately monitor risk of kidney rejection

Levels of a protein in the urine of kidney transplant recipients can distinguish those at low risk of developing kidney injury from those at high risk, a study suggests. The results also suggest that low levels of this protein, called CXCL9, can rule out rejection as a cause of kidney injury.

23 Aug 2013

Novel Approach Developed On Antitumor Immunotherapy

...

22 Aug 2013

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.

22 Aug 2013

Scientists reveal why TB is a successful pathogen

By any measure, tuberculosis is a wildly successful pathogen. It infects as many as two billion people in every corner of the world, with a new infection of a human host estimated to occur every second.

22 Aug 2013

In dynamic mind-body interaction, brain recruits cells from immune system to promote anxiety

New research shows that in a dynamic mind-body interaction during the interpretation of prolonged stress, cells from the immune system are recruited to the brain and promote symptoms of anxiety.

22 Aug 2013

Kentucky researcher uses advanced biomedical technology to study HMPV

You may not know the human metapneumovirus by name, but chances are that you have met somewhere before.

22 Aug 2013

New antibody drug shows positive results for treating Crohn's disease, ulcerative colitis

Vedolizumab, a new intravenous antibody medication, has shown positive results for treating both Crohn's disease and ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. The findings, published in two papers, will appear in the August 22 issue of the New England Journal of Medicine (NEJM).

22 Aug 2013

UC Davis Health System develops new screening strategy for lethal stage of TB in Asia

More than 20,000 people in Pakistan are being tested for the potentially deadly stage of tuberculosis using a new strategy developed at UC Davis Health System to effectively detect the disease in children for the first time.

22 Aug 2013

FDA approves first mass spectrometer system in U.S. for identification of bacteria, yeasts

The U.S. Food and Drug Administration today allowed marketing in the U.S. of the first mass spectrometer system for automated identification of bacteria and yeasts that are known to cause serious illness in humans.

22 Aug 2013

Hypertension researcher receives Distinguished Scientist title from AHA

Kenneth Bernstein, MD, a Cedars-Sinai pathologist and scientific researcher known for expanding the understanding of a collection of proteins important in controlling blood pressure as well as heart and renal diseases, has been named a 2013 Distinguished Scientist by the American Heart Association.

21 Aug 2013

Immune System News and Research

Houston scientists receive $1.3M grant to study how immune system drives multiple sclerosis

Model including dozens of mutations helps clarify genetic factors involved in Crohn's disease

BES procedure may prevent cell apoptosis in stem cell-based transplantation therapy

Early antiretroviral therapy treatment benefits HIV-infected infants

Hope for hand amputees: Researchers test new method for local immunosuppression

Understanding genetic factors that affect Crohn's disease risk

Moffitt Cancer Center study could offer hope to melanoma sufferers

Seven researchers to receive grants from ASTRO to advance radiation oncology research

ATF3 gene may be the crucial link between stress and breast cancer: Study

Study shows how microbes cooperate with sex hormones to affect immune system

Noninvasive urine test can accurately monitor risk of kidney rejection

Novel Approach Developed On Antitumor Immunotherapy

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Scientists reveal why TB is a successful pathogen

In dynamic mind-body interaction, brain recruits cells from immune system to promote anxiety

Kentucky researcher uses advanced biomedical technology to study HMPV

New antibody drug shows positive results for treating Crohn's disease, ulcerative colitis

UC Davis Health System develops new screening strategy for lethal stage of TB in Asia

FDA approves first mass spectrometer system in U.S. for identification of bacteria, yeasts

Hypertension researcher receives Distinguished Scientist title from AHA

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News